CN108245616A - A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof - Google Patents

A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof Download PDF

Info

Publication number
CN108245616A
CN108245616A CN201611249171.3A CN201611249171A CN108245616A CN 108245616 A CN108245616 A CN 108245616A CN 201611249171 A CN201611249171 A CN 201611249171A CN 108245616 A CN108245616 A CN 108245616A
Authority
CN
China
Prior art keywords
parts
glycometabolism
adjustment sheet
extract powder
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611249171.3A
Other languages
Chinese (zh)
Inventor
宋如顺
劳乔聪
汤敏佳
朱晓宇
李春启
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANGZHOU HUNTER BIOTECHNOLOGY CO Ltd
Original Assignee
HANGZHOU HUNTER BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANGZHOU HUNTER BIOTECHNOLOGY CO Ltd filed Critical HANGZHOU HUNTER BIOTECHNOLOGY CO Ltd
Priority to CN201611249171.3A priority Critical patent/CN108245616A/en
Publication of CN108245616A publication Critical patent/CN108245616A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of glycometabolism adjustment sheets containing pure plant, are made of the raw material and pharmaceutically acceptable auxiliary material that contain following parts by weight, in terms of the adjustment sheet of 1000 parts by weight, contained feed components and its content are：10 800 parts of Chinese cassia tree, 5 280 parts of Chinese yam, 5 240 parts of sealwort.A kind of glycometabolism adjustment sheet provided by the invention, Formulation is scientific and reasonable, and there is no incompatibility, active ingredient combination can play synergistic effect；It is convenient to take, conducive to absorption, work quick, can effectively reduce the hyperglycemia of diabetic, and beta Cell of islet is promoted to regenerate, play treating both manifestation and root cause of disease effect, be it is a can the edible multi-selection product of medicine.

Description

A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof
Technical field
The present invention relates to a kind of food and field of health care food, more particularly to a kind of piece with glycometabolism adjustment effect Agent, can Effective Regulation diabetes glucose and improvement islet beta cell function.
Background technology
According to statistics, global diabetic in 2014 is up to 3.87 hundred million people, dead 4,900,000 people, International Diabetes Federation (IDF) it expects diabetic in 2035 and reaches 5.92 hundred million, increase by 55%[1].With the rapid development of economy, people live The change of custom, in blowout situation, up to 1.14 hundred million, IDF in 2014 is expected 2035 to be increased China diabetic within nearly 10 years 1.43 hundred million are added to, China has become the most country of diabetic.Diabetes are one group of generations characterized by hyperglycemia Thanking property disease, hyperglycemia be then since defect of insulin secretion or its biological effect are damaged, or both have concurrently and cause；70% pancreas Island cell is β cells, can excreting insulin, play a part of to adjust blood glucose, if β cell functions are damaged, insulin secretion it is absolute or Relative deficiency, so as to cause diabetes.Therefore, promote β cytothesises, improve islet cell function, just become prevention diabetes Research hot topic.
The animal model of research diabetes mainly has 4 classes at present, respectively：Induction type animal model, spontaneous heredity are dynamic Object model, pancreas part excision animal model and transgenic animal model.Using it is more be induction type animal model, but exist Following deficiency：(1) processing of induction type diabetes animal model is various, lacks unified working specification；(2) weigh model into Standard whether work(is irregular, and causing application factor influences model quality；(3) pathophysiological change of animal model and sugar The pathophysiological change of the sick clinical patients of urine still has gap, and the theory of animal model cannot be entirely applied to clinical patients.
Zebra fish is a kind of common tropical fish, and due to raising, easy, embryo is transparent, in vitro fertilization, mutant variety is more, heredity Many advantages, such as tool is ripe has become the emerging model animal of new drug development in recent years.Due to zebra fish gene and the mankind The similarity of gene reaches 87%, it means that the obtained result of drug study is done with it and is also suitable in most cases In human body[2-10].Research shows that zebra fish has, the homology of zebra fish pancreas and human pancreatic are very high, and the structure of pancreas Similar with ingredient to the mankind, glucose-regulating mechanism is highly consistent with mammal, and the zebra fish diabetes model of structure is successfully commented The hypoglycemic medicines such as valency biguanides, alpha-glucosidase restrainer and sulfonylureas, are as a result consistent with clinic[11-14]。
Present invention applicant carries out hypoglycemic effect using zebra fish diabetes model and promotees β cytothesis evaluation of effect, sees Intuitive, analysis simplicity is examined, it is as a result objective reliable.
In presently commercially available hypoglycemic pcm or patent, equal existence component is complicated, and there are security risk, hypoglycemics for long-term use The defects of mechanism of action is unclear, and hypoglycemic effect is imprecise.Such as hypoglycemic Tongmai Tablet, main component are：Radix pseudostellariae, Radix Astragali, sealwort, Asparagus fern, Radix Ophiopogonis, radix scrophulariae, root of Chinese trichosanthes, rhizoma atractylodis, rhizoma anemarrhenae, pueraria lobata, the coptis, Radix Salviae Miltiorrhizae, motherwort, the radix paeoniae rubrathe, leech, radix cyathulae, chicken blood Rattan, the root of Chinese clematis, semen litchi, earthworm, Rhizoma Chuanxiong, major function：Supplementing qi and nourishing yin, promoting blood circulation and removing blood stasis, clearing and activating the channels and collaterals, for deficiency of both vital energy and Yin, It quenches one's thirst caused by obstruction of collaterals by blood stasis, drinks more, more foods, diuresis, becomes thin, weak and type-2 diabetes mellitus is shown in above-mentioned patient.For another example join stilbene Melbine, main component are：Ginseng (cauline leaf) saponin(e, Schisandra chinensis, Radix Astragali, Chinese yam, glutinous rehmannia, raspberry, Radix Ophiopogonis, Poria cocos, smallpox Powder, rhizoma alismatis, the fruit of Chinese wolfberry, major function：Supplementing qi and nourishing yin grows spleen kidney tonifying, diabetes is cured mainly, for type II diabetes.Patent document Aspect, such as the Chinese invention patent of Publication No. CN101336974B disclose a kind of with overall regulation of body metabolism machine Hypoglycemic fat-regulating Chinese medicine of energy and preparation method thereof, which is by Radix Astragali, gynostemma pentaphylla, pueraria lobata, mulberry leaf, faenum graecum, the coptis, Chinese cassia tree Manufactured medicament in proportion.The for another example Chinese invention patent of Publication No. CN102861263B discloses a kind of pure Chinese medicine hypoglycemic Preparation, the Chinese medicine be by Radix Astragali, sealwort, balsam pear, pueraria lobata, radix polygonati officinalis, the root bark of Chinese wolf-berry, Poria cocos, hairyvein agrimony, Chinese yam, oyster, Herba Epimedii, Chrysanthemum, mulberry leaf, coix seed.The compound for reducing blood suger of above-mentioned existing antihypelipidemic product or patent literature, pharmacological mechanism Do not consider from activation 'inertia' insulin, improvement islet beta cell function.
To sum up, how a kind of blood glucose of energy Effective Regulation diabetic population is provided, and is effectively improved the pancreas of diabetic population The glycometabolism adjustment sheet containing pure plant of island β cell functions is that those skilled in the art are badly in need of the technical barrier solved.
Invention content
Present invention aims at a kind of glycometabolism adjustment sheet preparation method containing pure plant is provided, can not only drop Hypoglycemia, it is without side-effects, can effectively activate 'inertia' insulin, and protect islet cells, and mild in medicine property and, be easy to absorb, It is the pure Chinese medicine antihypelipidemic preparation for treating diabetes, solves and above-mentioned be previously mentioned related defects in the prior art.
For achieving the above object, this invention takes following technical schemes：
A kind of glycometabolism adjustment sheet containing pure plant, by containing the raw material of following parts by weight and pharmaceutically acceptable Auxiliary material forms, and in terms of the adjustment sheet of 1000 parts by weight, contained feed components and its content are：10-800 parts of Chinese cassia tree, Chinese yam 5-280 parts, 5-240 parts of sealwort.
Preferably, extract powder is made in the raw material in a manner of extracting.
It is furthermore preferred that the raw material extract powder is made by the following method：Suitable Chinese cassia tree or Chinese yam or sealwort are taken, is added Water extracts n times, merges the extracting solution that extracts every time, filters, and is concentrated under reduced pressure, be spray-dried to get.
It is furthermore preferred that in the extract powder extraction process, times N >=2 of extraction, extraction time is 1~4 hour.
Preferably, the auxiliary material include diluent and lubricant, wherein diluent for microcrystalline cellulose, starch, dextrin, One or more of amylum pregelatinisatum, calcium sulfate, calcium monohydrogen phosphate, medicinal calcium carbonate, mannitol；Lubricant for magnesium stearate, One or more of superfine silica gel powder, talcum powder and silica.
It is furthermore preferred that being made of in the auxiliary material diluent and lubricant, wherein diluent is microcrystalline cellulose, is lubricated Agent is magnesium stearate.
Preferably, it is made of the raw material and pharmaceutically acceptable auxiliary material that contain following parts by weight, with 1000 parts by weight Adjustment sheet meter, contained feed components and its content are：10-800 parts of Chinese cassia tree, 5-280 parts of Chinese yam, 5-240 parts of sealwort, crystallite 20-975 parts of cellulose, 5-20 parts of magnesium stearate.
A kind of method for preparing the glycometabolism adjustment sheet containing pure plant as previously described, includes the following steps：
1) appropriate Chinese cassia tree is taken, extracting in water 2 times, 1~4 hour every time, the quantity of solvent added by first time extracting in water was medicine 6~30 times of amount of material weight, the solvent added for the second time are 5~25 times of medicinal material weight；Merge extracting solution, filtration is depressurized dense Contracting, spray drying, obtains Chinese cassia tree extract powder；
2) appropriate Chinese yam is taken, extracting in water 2 times 1~4 hour every time, adds the quantity of solvent added by extraction with aqueous solution for the first time It is 6~30 times of amount of medicinal material weight, the solvent added for the second time is 6~25 times of medicinal material weight, merges extracting solution, and filtration subtracts Pressure concentration, spray drying obtain Chinese yam extract powder；
3) appropriate sealwort is taken, extracting in water 2 times, 1~4 hour every time, the water added by first time extracting in water was medicinal material 6~20 times of water of weight, the water added for the second time are 5~15 times of medicinal material weight, merge extracting solution, and filtration is depressurized dense Contracting, spray drying, obtains huang jing extract powder；
4) take respectively recipe quantity step 1), 2) and 3) made from Chinese cassia tree extract powder, Chinese yam extract powder and huang jing extract powder, Add in auxiliary material, mix, sieving, direct tablet compressing to get.
The prescription principle and advantage of the present invention is as follows：
1st, Chinese cassia tree, Chinese yam and sealwort are to be embodied in 2015 editions in prescription《Chinese Pharmacopoeia》Medical and edible dual purpose plant, easily It obtains, and without any toxicity, three taste Chinese medicines are at 2015 editions《Chinese Pharmacopoeia》In function it is specific as follows with curing mainly：
Chinese cassia tree：It mends fire and helps PFK guiding fire to origin, eliminating cold to stop pain, warm promoting menstruation, for positive fistula Gong Leng, waist Teng's crymodynia, kidney Virtual makees Asthma, Virtual sun float, dizziness hot eyes , Xin Peep crymodynias, cold of insufficiency type vomiting and diarrhea, pain of trembling with fear abdominal pain, dysmenorrhoea Amenorrhea.
Chinese yam：Tonifying spleen nourishing the stomach, engender liquid and benefic lung, the puckery essence of kidney tonifying.For spleen eating less, endless diarrhea, the deficiency syndrome of the lung is breathed with cough, and kidney deficiency is lost Essence, under, frequent micturition, abnormal heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) good efficacy to suffering from a deficiency of the kidney.For spleen eating less, diarrhea loose stool, leukorrhea.
Sealwort：Boosting qi and nourishing yin, invigorating the spleen, moistening lung, kidney-nourishing.For deficiency of spleen-QI and stomach-QI, fatigue and asthenia, deficiency of stomach-Yin, dry deficiency of food, Deficiency syndrome of the lung cough caused by dryness, overstrain cough hemoptysis, asthenia of essence and blood, soreness and weakness of waist and knees, poliosis, Heat Diabetes.
2nd, this three tastes Chinese medicine of Chinese cassia tree, Chinese yam and sealwort is respectively provided with different pharmacological actions, has different classes of cure mainly Function is to be combined comprising three taste Chinese medicines in presently commercially available antihypelipidemic product.The present invention has found through investigative test, by Chinese cassia tree, Chinese yam and three taste Chinese medicine of sealwort are combined jointly, and monarch, minister, the adjutant division of labor are clear and definite, can be synergistic, activate 'inertia' pancreas islet Element has apparent facilitation to beta Cell of islet regeneration, therefore can have significant function of reducing blood sugar.
3rd, pure plant glycometabolism adjustment sheet of the invention, is a kind of oral conventional tablet, by the prescription system of the present invention Into this one dosage type low temperature, considered based on following：1. dosage is accurate；2. stable quality；3. production mechanization, high degree of automation；4. it takes With, carry, storage it is convenient, good mouthfeel, it is good that patient takes compliance；5. absorb rapid, quick acting.
In short, a kind of pure plant glycometabolism adjustment sheet provided by the invention, is mainly made of medical and edible dual purpose plant, place Design is scientific and reasonable for side, and there is no incompatibility, active ingredient combination can play synergistic effect；For oral tablet, clothes With conveniently, conducive to absorption, work quick, can effectively reduce the hyperglycemia of diabetic, and beta Cell of islet is promoted to regenerate, rise To treating both manifestation and root cause of disease effect, be it is a can the edible multi-selection product of medicine.
Description of the drawings
Fig. 1 is blood sugar reducing function effect of this five kinds of glycometabolism adjustment sheets of the embodiment of the present invention 1~5.
Fig. 2 is rush beta Cell of islet palingenesis effect of this five kinds of glycometabolism adjustment sheets of the embodiment of the present invention 1~5.
Specific embodiment
The following is specific embodiments of the present invention, and technical scheme of the present invention is further described, but of the invention Protection domain be not limited to these embodiments.It is every to be included in this hair without departing substantially from the change of present inventive concept or equivalent substitute Within bright protection domain.
Embodiment 1：
Formula 1：In terms of 1000 parts,
10 parts of 5 parts of Chinese yam extract powders of Chinese cassia tree extract powder
5 parts of huang jing extract powder, 975 parts of microcrystalline cellulose
5 parts of magnesium stearate
Preparation process：Take the above-mentioned raw materials and auxiliary material of recipe quantity, mix, sieving, direct tablet compressing to get.Piece weight is 0.5g.
Embodiment 2：
Formula 2：In terms of 1000 parts,
110 parts of 70 parts of Chinese yam extract powders of Chinese cassia tree extract powder
60 parts of huang jing extract powder, 750 parts of microcrystalline cellulose
10 parts of magnesium stearate
Preparation process：Take the above-mentioned raw materials and auxiliary material of recipe quantity, mix, sieving, direct tablet compressing to get.Piece weight is 0.5g.
Embodiment 3：
Formula 3：In terms of 1000 parts,
220 parts of 140 parts of Chinese yam extract powders of Chinese cassia tree extract powder
120 parts of huang jing extract powder, 510 parts of microcrystalline cellulose
10 parts of magnesium stearate
Preparation process：Take the above-mentioned raw materials and auxiliary material of recipe quantity, mix, sieving, direct tablet compressing to get.Piece weight is 0.5g.
Embodiment 4：
Formula 4：In terms of 1000 parts,
330 parts of 210 parts of Chinese yam extract powders of Chinese cassia tree extract powder
180 parts of huang jing extract powder, 260 parts of microcrystalline cellulose
20 parts of magnesium stearate
Preparation process：Take the above-mentioned raw materials and auxiliary material of recipe quantity, mix, sieving, direct tablet compressing to get.Piece weight is 0.5g.
Embodiment 5：
Formula 5：In terms of 1000 parts,
720 parts of 60 parts of Chinese yam extract powders of Chinese cassia tree extract powder
60 parts of huang jing extract powder, 150 parts of microcrystalline cellulose
10 parts of magnesium stearate
Preparation process：Take the above-mentioned raw materials and auxiliary material of recipe quantity, mix, sieving, direct tablet compressing to get.Piece weight is 0.5g.
Embodiment 6：The blood sugar reducing function evaluation experimental of glycometabolism adjustment sheet of the present invention
1st, experimental animal
Wild type AB systems zebra fish, with fish culture water culture (breeding fish) water water quality under the conditions of 28 DEG C：It is reverse osmosis per 1L 200mg Instant Oceans are added in water, conductivity is 480~510 μ S/cm；PH is 6.9~7.2；Hardness is 53.7~71.6mg/L CaCO3).4~5 pairs of zebra fish parent mating are taken, according to the method hatched blastocyst of Westerfield [15].The best of it will be in The zebra fish in reason stage is placed under disecting microscope and observes, and the normotrophic zebra fish of picking is moved into 6 hole microwell plates.It has tested Cheng Hou carries out over-exposure processing with the zebra fish of tricaine methanesulfonic acid pair, is put to death so as to which zebra fish be anaesthetized.What anesthesia was put to death Operating procedure meets the code requirement that American Veterinary association (AVMA) puts to death Animal Anesthesia.
2nd, by reagent：
The 5 kinds of glycometabolism adjustment sheets prepared by the method for Examples 1 to 5 are labeled as formula 1, formula 2, match successively Side 3, formula 4, formula 5.
3rd, laboratory apparatus and reagent
Metformin hydrochloride (Aladdin, 1127991)；Alloxan (Sigma companies, 05760)；Glucose (Jhansi Red Star pharmaceutcal corporation, Ltd, S120720)；Blood glucose meter (Accu-Che, Performa, Roche).
4th, experimental method
Wild type AB system zebra fish is randomly selected in 6 orifice plates, per 30 tail of hole, with alloxan and glucose Combined Treatment Establish zebra fish hyperglycemia model；Water-soluble respectively to give formula 1, formula 2, formula 3, formula 4 and formula 5, concentration is 100 μ G/mL, per hole 3mL liquids, positive controls are water-soluble to give melbine 10 μ g/mL concentration, while set Normal group and mould Type control group.Zebra fish is collected after experiment, glucose content measure (S), statistical procedures result are carried out using blood glucose meter It is represented with mean ± SE, adjustment sheet blood sugar reducing function calculation formula is as follows：Blood sugar reducing function (%)=[(S model control group-S test samples Group) ÷ (S model control group-S Normal groups)] × 100%；With variance analysis and Dunnett ' s T- inspection carry out statistics Analysis, p<0.05 shows with significant difference, provides representative experimental patterns.
5th, experimental result
Model control group zebra fish dextrose equivalent (3.76nmol/fish) is Normal group (1.1n mol/fish) 3.4 times, the two compares p<0.001, display zebra fish hyperglycemia model is successfully established；10 μ g/mL hypoglycemic rates of melbine are 19.55%, the p compared with model control group<0.05, display melbine has blood sugar reducing function.
This five kinds of glycometabolism adjustment sheets of the embodiment of the present invention 1~5, hypoglycemic rate difference 22.56%, 30.73%, 45.86%th, 39.85% and 36.09%, the p compared with model control group<0.01&p<0.001&p<0.001&p<0.001, display 5 Kind glycometabolism adjustment sheet has apparent blood sugar reducing function, and blood sugar reducing function is respectively from high to low：Formula 3>Formula 4>Formula 5>Match Side 2>Formula 1, the results showed that：Formula 3 is optimization formula.
Refer to table 1 and Fig. 1.
1. glycometabolism adjustment sheet of table, 5 kinds of formula function of reducing blood sugar evaluation results (n=5)
Compared with model control group, * p<0.05,**p<0.01,***p<0.001
Embodiment 7：The rush beta Cell of islet palingenesis evaluation experimental of glycometabolism adjustment sheet of the present invention
1st, experimental animal
Transgenosis beta Cell of islet fluorescence zebra fish, with fish culture water culture (breeding fish) water water quality under the conditions of 28 DEG C：Often 200mg Instant Oceans are added in 1L reverse osmosis waters, conductivity is 480~510 μ S/cm；PH is 6.9~7.2；Hardness for 53.7~ 71.6mg/L CaCO3).4~5 pairs of zebra fish parent mating are taken, according to the method hatched blastocyst of Westerfield [15].It will place Zebra fish in the optimization process stage is placed under disecting microscope and observes, and the normotrophic zebra fish of picking moves into 6 hole microwell plates In.After the completion of experiment, over-exposure processing is carried out with the zebra fish of tricaine methanesulfonic acid pair, is put to death so as to which zebra fish be anaesthetized. The operating procedure that anesthesia is put to death meets the code requirement that American Veterinary association (AVMA) puts to death Animal Anesthesia.
2nd, by reagent：
The 5 kinds of glycometabolism adjustment sheets prepared by the method for Examples 1 to 5 are labeled as formula 1, formula 2, match successively Side 3, formula 4, formula 5.
3rd, laboratory apparatus and reagent
Metformin hydrochloride (Aladdin, 1127991)；Alloxan (Sigma companies, 05760)；Glucose (Jhansi Red Star pharmaceutcal corporation, Ltd, S120720)；6 orifice plates (Nest Biotech, Chinese Shanghai)；Fluorescence stereo microscope (SMZ645, Nikon, Japan)；Disecting microscope (SZX7, OLYMPUS, Japan)；Power focus continuous zoom fluorescence microscope (AZ100, Nikon, Japan).
4th, experimental method
Transgenosis beta Cell of islet fluorescence zebra fish is randomly selected in six orifice plates, per 30 tail of hole, with alloxan and grape Sugared Combined Treatment establishes zebra fish hyperglycemia model.It is water-soluble respectively to give formula 1, formula 2, formula 3, be formulated 4 and formula 5, it is dense Degree is 100 μ g/mL, per hole 3mL liquids, while sets Normal group and model control group.It is small that 28 DEG C of incubators are incubated 24 Shi Hou, every group takes 10 tail zebra fish to observe, take pictures under the microscope and preserves picture at random；Image is carried out with image analysis software Analysis calculates zebra fish beta Cell of islet fluorescence intensity (S), carries out quantitative analysis, and statistical procedures result is represented with X ± SE；It adjusts It is as follows that nodal plate promotees beta Cell of islet palingenesis calculation formula：β cytothesises rate (%)=(1-S test sample group ÷ S model comparisons Group) × 100%；With variance analysis and Dunnett ' s T- inspection carry out statistical analysis, p<0.05 show it is poor with conspicuousness It is different.
5th, experimental result
The fluorescence intensity (98264) of model control group p compared with Normal group (169919)<0.001, show zebra fish The success of beta Cell of islet Establishing an injured model.5 kinds of glycometabolism adjustment sheet formula hypoglycemic rates difference 40.18%, 56.51%, 91.52%th, 76.08% and 60.09%, the p compared with model control group<0.01&p<0.001&p<0.001&p<0.001, display 5 Kind glycometabolism adjustment sheet has apparent rush beta Cell of islet regeneration effect, and effect is respectively formula 3 from high to low>Formula 4>Match Side 5>Formula 2>Formula 1, as a result prompting formula 3 is optimization formula.
Refer to table 2 and Fig. 2.
2. glycometabolism adjustment sheet of table, 5 kinds of formulas promote beta Cell of islet palingenesis evaluation result (n=10)
Compared with model control group, * * p<0.01,***p<0.001
It is attached：Bibliography
[1]IDF.International Diabetes Federation.Retrieved 29November 2014.
[2]McGrath P,Li CQ.Zebrafish:a predictive model for assessing drug- induced toxicity[J].Drug Discov Today,2008,13:394-401.
[3]He J H,Guo S Y,Zhu F,et al.A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity[J].J Pharmacol Toxicol Methods,2013,67: 25-32.
[4]Yang R,Lao QC,Yu HP,et al.Tween-80and Impurity Induce Anaphylactoid Reaction in Zebrafish[J].J Appl Toxicol,2015,35:295-301.
[5]Xu M,Lao QC,Zhao P,et al.6′-O-Caffeoylarbutin inhibits melanogenesis in zebrafish[J].Nat Prod Res,2014,28:932-934.
[6]Zhou J,Guo S Y,Zhang Y,et al.Human prokinetic drugs promote gastrointestinal motility in zebrafish[J].Neurogastroenterol Motil,2014,26: 589-595.
[7]Zhu J J,Xu Y Q,He J H,et al.Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish[J].J Appl Toxicol,2014,34:139-148.
[8]Zhou J,Xu YQ,Guo SY,Li CQ.Rapid analysis of hypolipidemic drugs in a live zebrafish assay.J Pharmacol Toxicol Methods,2015,72:47-52.
[9]Li JL,Zhou J,Chen ZH,et al.Bioactive C 21Steroidal Glycosides from the Roots of Cynanchum otophyllum That Suppress the Seizure-like Locomotor Activity of Zebrafish Caused by Pentylenetetrazole.J Nat Prod.2015,24；78(7): 1548-1555.
[10]Xu H,Dong X,Zhang Z,et al.Assessment of immunotoxicity of dibutyl phthalate using live zebrafish embryos.Fish&Shellfish Immunology,2015,45:286- 292.
[11]Pisharath H,Rhee JM,Swanson MA,et al.Targeted ablation of beta cells in the embryonic zebrafish pancreas using E.coli nitroreductase.Mech Dev.2007,124:218-29
[12]Elo B,Villano CM,Govorko D,White LA.Larval zebrafish as a model for glucose metabolism:expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds.J Mol Endocrinol.2007,38:433- 40.
[13]Jurczyk A1,Roy N,Bajwa R,et al.Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish.Gen Comp Endocrinol.2011,15；170:334-45.
[14]Gut P,Baeza-Raja B,Andersson O,Hasenkamp L,et al.Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism.Nat Chem Biol.2013,9:97-104
[15]Westerfield M.The Zebrafish Book:A Guide for the Laboratory Use of Zebrafish.Eugene,Oregon:The University of Oregon Press,1993。

Claims (8)

1. a kind of glycometabolism adjustment sheet containing pure plant, by containing the raw material of following parts by weight and pharmaceutically acceptable auxiliary Material composition, in terms of the adjustment sheet of 1000 parts by weight, contained feed components and its content are：10-800 parts of Chinese cassia tree, Chinese yam 5- 280 parts, 5-240 parts of sealwort.
2. the glycometabolism adjustment sheet according to claim 1 containing pure plant, which is characterized in that the raw material with Extract powder is made in the mode of extraction.
3. the glycometabolism adjustment sheet according to claim 2 containing pure plant, which is characterized in that the raw material medicinal extract Powder is made by the following method：Suitable Chinese cassia tree or Chinese yam or sealwort are taken, extracting in water n times merge the extracting solution extracted every time, Filtration, be concentrated under reduced pressure, be spray-dried to get.
4. the glycometabolism adjustment sheet according to claim 3 containing pure plant, which is characterized in that the extract powder carries In taking technique, times N >=2 of extraction, extraction time is 1~4 hour.
5. the glycometabolism adjustment sheet according to claim 1 containing pure plant, which is characterized in that the auxiliary material includes Diluent and lubricant, wherein diluent are microcrystalline cellulose, starch, dextrin, amylum pregelatinisatum, calcium sulfate, calcium monohydrogen phosphate, medicine With one or more of calcium carbonate, mannitol；Lubricant is in magnesium stearate, superfine silica gel powder, talcum powder and silica It is one or more of.
6. the glycometabolism adjustment sheet according to claim 5 containing pure plant, which is characterized in that in the auxiliary material by Diluent and lubricant composition, wherein diluent is microcrystalline cellulose, and lubricant is magnesium stearate.
7. according to the glycometabolism adjustment sheet according to any one of claims 1 to 6 containing pure plant, which is characterized in that by Raw material containing following parts by weight and pharmaceutically acceptable auxiliary material composition, in terms of the adjustment sheet of 1000 parts by weight, contained original Material each component and its content are：It is 10-800 parts of Chinese cassia tree, 5-280 parts of Chinese yam, 5-240 parts of sealwort, 20-975 parts of microcrystalline cellulose, hard 5-20 parts of fatty acid magnesium.
8. a kind of prepare such as the method for the glycometabolism adjustment sheet according to any one of claims 1 to 6 containing pure plant, packet Include following steps：
1) appropriate Chinese cassia tree is taken, extracting in water 2 times, 1~4 hour every time, the quantity of solvent added by first time extracting in water was medicinal material weight 6~30 times of amount of amount, the solvent added for the second time are 5~25 times of medicinal material weight；Merge extracting solution, filter, be concentrated under reduced pressure, spray Mist is dried, and obtains Chinese cassia tree extract powder；
2) appropriate Chinese yam is taken, extracting in water 2 times, 1~4 hour every time, for the first time plus the quantity of solvent added by extraction with aqueous solution was medicine 6~30 times of amount of material weight, the solvent added for the second time are 6~25 times of medicinal material weight, merge extracting solution, and filtration is depressurized dense Contracting, spray drying, obtains Chinese yam extract powder；
3) appropriate sealwort is taken, extracting in water 2 times, 1~4 hour every time, the water added by first time extracting in water was medicinal material weight 6~20 times of water, second plus water be 5~15 times of medicinal material weight, merge extracting solution, filter, be concentrated under reduced pressure, spray Mist is dried, and obtains huang jing extract powder；
4) take respectively recipe quantity step 1), 2) and 3) made from Chinese cassia tree extract powder, Chinese yam extract powder and huang jing extract powder, add in Auxiliary material, mix, sieving, direct tablet compressing to get.
CN201611249171.3A 2016-12-29 2016-12-29 A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof Pending CN108245616A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611249171.3A CN108245616A (en) 2016-12-29 2016-12-29 A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611249171.3A CN108245616A (en) 2016-12-29 2016-12-29 A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108245616A true CN108245616A (en) 2018-07-06

Family

ID=62721633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611249171.3A Pending CN108245616A (en) 2016-12-29 2016-12-29 A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108245616A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110714026A (en) * 2019-10-22 2020-01-21 闽南师范大学 Construction method and application of type II diabetic zebra fish model
CN115364170A (en) * 2022-10-20 2022-11-22 云南中医药大学 Sugar metabolism regulator and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102599518A (en) * 2012-03-24 2012-07-25 青岛好管家商务有限公司 Production method of specially-made sea cucumber capsule
CN105435170A (en) * 2015-12-11 2016-03-30 张量才 Edible and medicinal traditional Chinese medicine health foodstuff

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102599518A (en) * 2012-03-24 2012-07-25 青岛好管家商务有限公司 Production method of specially-made sea cucumber capsule
CN105435170A (en) * 2015-12-11 2016-03-30 张量才 Edible and medicinal traditional Chinese medicine health foodstuff

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王群，等: "张志远教授治疗糖尿病经验", 《中国中医药现代远程教育》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110714026A (en) * 2019-10-22 2020-01-21 闽南师范大学 Construction method and application of type II diabetic zebra fish model
CN115364170A (en) * 2022-10-20 2022-11-22 云南中医药大学 Sugar metabolism regulator and preparation method and application thereof
CN115364170B (en) * 2022-10-20 2023-01-24 云南中医药大学 Sugar metabolism regulator and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN102614499B (en) Yak skin collagen compound traditional Tibetan medicine with anti-fatigue effect and preparation process thereof
CN102988827A (en) Dendrobium officinale granula
CN105031591B (en) A kind of Chinese medicine composition and preparation method thereof for treating chronic renal failure
CN108245616A (en) A kind of glycometabolism adjustment sheet containing pure plant and preparation method thereof
CN1267144C (en) Compound diabetes-treating sugar-decreasing fat-reducing preparation and preparation method thereof
CN102813850B (en) Traditional Chinese medicine composition for preventing and treating poultry coccidiosis and preparation method of traditional Chinese medicine composition
CN106177183A (en) A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, green tea and Folium Mori
CN112915131A (en) Traditional Chinese medicine composition with fat burning function
CN105125946A (en) Gardenia oral liquid clearing away heart fire and relieving restlessness and preparing method thereof
CN103251802A (en) Appearance paste and preparation method thereof
CN101019897B (en) Antitumor medicine composition and its preparation method
CN104623068B (en) Treat medicine of fever in children infantile convulsion and preparation method thereof
CN104587175B (en) A kind of Chinese medicine preparation for treating diabetes
CN102357151A (en) Chinese medicinal composition for delaying senility and preparation process thereof
CN104257755A (en) Composition with effect of treating diabetes as well as preparation method and application of composition
CN111528476A (en) Compatible composition of ginseng and rhizoma polygonati honey tablets and preparation method
CN106177416B (en) A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof
CN104107323B (en) A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof
CN103932176A (en) Health-care food composition for assisting to lower blood flat, as well as preparation method and application of composition
CN103386015A (en) A traditional Mongolian medicine for the treatment of diabetes
CN109528857A (en) A kind of campanulaceae particle and preparation method thereof for treating respiratory disease caused by haze
CN105560694A (en) Medicine composition for treating diabetic nephropathy and preparation method thereof
CN104983772B (en) Blue lotus oral solution and preparation method thereof for animal warm heat disease initial stage
CN104587176B (en) Treat the medicine of diabetes
CN103611046A (en) Manufacturing method of composition for treating rumen indigestion

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180706

RJ01 Rejection of invention patent application after publication